Schering’s Antibiotic Garenoxacin Gets Advisory Committee Date
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Anti-Infective Drugs Advisory Committee will discuss Schering-Plough's antibiotic garenoxacin on Sept. 11, according to a Federal Register pre-publication announcement July 24
You may also be interested in...
Schering-Plough Drops Garenoxacin NDA, But Leaves Door Open For Resubmission
Sept. 11 advisory committee meeting on antibiotic cancelled.
Schering-Plough Drops Garenoxacin NDA, But Leaves Door Open For Resubmission
Sept. 11 advisory committee meeting on antibiotic cancelled.
Oscient’s Factive To Get Advisory Committee Review For Acute Bacterial Sinusitis
FDA’s Anti-Infective Drugs Advisory Committee will review Oscient’s sNDA for the antibiotic Sept. 12.